Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

662 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with Guadecitabine.
O'Connell CL, Baer MR, Ørskov AD, Saini SK, Duong VH, Kropf P, Hansen JW, Tsao-Wei D, Jang HS, Emadi A, Holmberg-Thyden S, Cowland J, Brinker BT, Horwood K, Burgos R, Hostetter G, Youngblood BA, Hadrup SR, Issa JP, Jones P, Baylin SB, Siddiqi I, Grønbaek K. O'Connell CL, et al. Clin Cancer Res. 2022 Dec 15;28(24):5306-5316. doi: 10.1158/1078-0432.CCR-22-1810. Clin Cancer Res. 2022. PMID: 36222848 Free PMC article. Clinical Trial.
Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia.
Baer MR, Kogan AA, Bentzen SM, Mi T, Lapidus RG, Duong VH, Emadi A, Niyongere S, O'Connell CL, Youngblood BA, Baylin SB, Rassool FV. Baer MR, et al. Clin Cancer Res. 2022 Apr 1;28(7):1313-1322. doi: 10.1158/1078-0432.CCR-21-3729. Clin Cancer Res. 2022. PMID: 35091444 Free PMC article. Clinical Trial.
Positron production by x rays emitted by betatron motion in a plasma wiggler.
Johnson DK, Auerbach D, Blumenfeld I, Barnes CD, Clayton CE, Decker FJ, Deng S, Emma P, Hogan MJ, Huang C, Ischebeck R, Iverson R, Joshi C, Katsouleas TC, Kirby N, Krejcik P, Lu W, Marsh KA, Mori WB, Muggli P, O'Connell CL, Oz E, Siemann RH, Walz D, Zhou M. Johnson DK, et al. Phys Rev Lett. 2006 Oct 27;97(17):175003. doi: 10.1103/PhysRevLett.97.175003. Epub 2006 Oct 27. Phys Rev Lett. 2006. PMID: 17155479
Halo formation and emittance growth of positron beams in plasmas.
Muggli P, Blue BE, Clayton CE, Decker FJ, Hogan MJ, Huang C, Joshi C, Katsouleas TC, Lu W, Mori WB, O'Connell CL, Siemann RH, Walz D, Zhou M. Muggli P, et al. Phys Rev Lett. 2008 Aug 1;101(5):055001. doi: 10.1103/PhysRevLett.101.055001. Epub 2008 Jul 29. Phys Rev Lett. 2008. PMID: 18764398
Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemia.
Roboz GJ, Kantarjian HM, Yee KWL, Kropf PL, O'Connell CL, Griffiths EA, Stock W, Daver NG, Jabbour E, Ritchie EK, Walsh KJ, Rizzieri D, Lunin SD, Curio T, Chung W, Hao Y, Lowder JN, Azab M, Issa JJ. Roboz GJ, et al. Cancer. 2018 Jan 15;124(2):325-334. doi: 10.1002/cncr.31138. Epub 2017 Dec 6. Cancer. 2018. PMID: 29211308 Free PMC article. Clinical Trial.
Plasma-wakefield acceleration of an intense positron beam.
Blue BE, Clayton CE, O'Connell CL, Decker FJ, Hogan MJ, Huang C, Iverson R, Joshi C, Katsouleas TC, Lu W, Marsh KA, Mori WB, Muggli P, Siemann R, Walz D. Blue BE, et al. Phys Rev Lett. 2003 May 30;90(21):214801. doi: 10.1103/PhysRevLett.90.214801. Epub 2003 May 30. Phys Rev Lett. 2003. PMID: 12786559
Hose instability and wake generation by an intense electron beam in a self-ionized gas.
Deng S, Barnes CD, Clayton CE, O'Connell C, Decker FJ, Fonseca RA, Huang C, Hogan MJ, Iverson R, Johnson DK, Joshi C, Katsouleas T, Krejcik P, Lu W, Mori WB, Muggli P, Oz E, Tsung F, Walz D, Zhou M. Deng S, et al. Phys Rev Lett. 2006 Feb 3;96(4):045001. doi: 10.1103/PhysRevLett.96.045001. Epub 2006 Jan 30. Phys Rev Lett. 2006. PMID: 16486834
662 results